11:31 AM EDT, 06/24/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending higher Monday, rising 0.84% to 1,428.35 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company argenx (ARGX) and financial services company Banco Bilbao Vizcaya Argentaria ( BBVA ) , which increased 9.3% and 3.3% respectively. They were followed by biopharmaceutical company Grifols ( GRFS ) and pharmaceutical company Sanofi ( SNY ) , which were up 2.8% and 3% respectively.

The decliners from continental Europe were led by biotech firm Evaxion Biotech ( EVAX ) and medical device maker EDAP TMS ( EDAP ) , which fell 5.7% and 1.3% respectively. They were followed by furniture maker Natuzzi (NTZ) and telecommunications company VEON (VEON), which dropped 0.2% and 1.3% respectively.

From the UK and Ireland, the gainers were led by insurance firm Prudential (PUK) and biopharmaceutical company Amarin ( AMRN ) , which increased 7.9% and 7.4% respectively. They were followed by biopharmaceutical company Verona Pharma plc ( VRNA ) and tobacco company British American Tobacco ( BTI ) , which were up 3.4% and 2.1% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Biodexa Pharmaceuticals ( BDRX ) and Akari Therapeutics ( AKTX ) , which fell 6.6% and 0.3% respectively. They were followed by biotech firm Trinity Biotech ( TRIB ) and biopharmaceutical company Mereo BioPharma Group ( MREO ) 2.2% and 1.3% respectively.